- Filed
- Jul 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jun 27, 2025 | 439.81M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $46.14K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.53M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.58M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.28M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.59M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.8M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.86M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.05M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.19M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.95M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.03M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.58M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.77M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 438.94M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $6K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$466.36K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $899.82K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $3.38K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$335.72K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$315.76K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $587.44K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.02M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.61M |